• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1例肾输尿管切除术后10年出现腹膜后复发鳞状细胞癌的罕见病例。

A rare case of retroperitoneal recurrence as squamous cell carcinoma 10 years after nephroureterectomy.

作者信息

Uehara Koichiro, Onuki Tatsuaki, Ishibashi Yukari, Matsunuma Sayuki, Ishida Hiroaki, Kumagai Jiro, Murakami Takayuki

机构信息

Department of Urology Yokohama City Minato Red Cross Hospital Yokohama Kanagawa Japan.

Department of Pathology Yokohama City Minato Red Cross Hospital Yokohama Kanagawa Japan.

出版信息

IJU Case Rep. 2024 Nov 4;8(1):56-59. doi: 10.1002/iju5.12809. eCollection 2025 Jan.

DOI:10.1002/iju5.12809
PMID:39749305
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11693096/
Abstract

INTRODUCTION

Local recurrence for upper tract urothelial carcinoma typically occurs within 2 years post-surgery. We report a rare case of retroperitoneal recurrence as squamous cell carcinoma 10 years after nephroureterectomy.

CASE PRESENTATION

A 67-year-old female was referred to our urology department for a left ureteral tumor. The surgical specimen of the laparoscopic left nephroureterectomy revealed urothelial carcinoma at the pT3 stage. Ten years post-nephroureterectomy, magnetic resonance cholangiopancreatography revealed a mass lesion in the left retroperitoneum, a computed tomography-guided biopsy revealed squamous cell carcinoma. Despite suspected distant metastases of other organ tumors, examinations such as digestive endoscopy and bronchoscopy did not reveal any tumor lesions. The patient was diagnosed with recurrent invasive urothelial carcinoma as a pathological feature of squamous cell carcinoma.

CONCLUSION

The decision-making process for treating malignant tumors, such as in cases with recurrence as squamous cell carcinoma, can be challenging.

摘要

引言

上尿路尿路上皮癌的局部复发通常发生在手术后2年内。我们报告一例罕见病例,在肾输尿管切除术后10年出现腹膜后复发,病理类型为鳞状细胞癌。

病例介绍

一名67岁女性因左侧输尿管肿瘤转诊至我院泌尿外科。腹腔镜下左侧肾输尿管切除术的手术标本显示为pT3期尿路上皮癌。肾输尿管切除术后10年,磁共振胰胆管造影显示左腹膜后有一肿块,计算机断层扫描引导下活检显示为鳞状细胞癌。尽管怀疑其他器官肿瘤有远处转移,但消化内镜和支气管镜等检查未发现任何肿瘤病变。该患者被诊断为复发性浸润性尿路上皮癌,病理特征为鳞状细胞癌。

结论

对于鳞状细胞癌复发等恶性肿瘤的治疗决策过程可能具有挑战性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7a/11693096/c649b37bf401/IJU5-8-56-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7a/11693096/86034fcae9da/IJU5-8-56-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7a/11693096/55a5237f00ff/IJU5-8-56-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7a/11693096/006fa4265d90/IJU5-8-56-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7a/11693096/c649b37bf401/IJU5-8-56-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7a/11693096/86034fcae9da/IJU5-8-56-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7a/11693096/55a5237f00ff/IJU5-8-56-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7a/11693096/006fa4265d90/IJU5-8-56-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7a/11693096/c649b37bf401/IJU5-8-56-g002.jpg

相似文献

1
A rare case of retroperitoneal recurrence as squamous cell carcinoma 10 years after nephroureterectomy.1例肾输尿管切除术后10年出现腹膜后复发鳞状细胞癌的罕见病例。
IJU Case Rep. 2024 Nov 4;8(1):56-59. doi: 10.1002/iju5.12809. eCollection 2025 Jan.
2
Rapid recurrence of squamous cell carcinoma at a lymphocele after nephroureterectomy: A rare case report.肾输尿管切除术后淋巴管囊肿处鳞状细胞癌快速复发:一例罕见病例报告。
IJU Case Rep. 2021 Feb 15;4(2):118-121. doi: 10.1002/iju5.12259. eCollection 2021 Mar.
3
Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review.腹腔镜肾输尿管切除术与开放根治性肾输尿管切除术治疗上尿路尿路上皮癌的肿瘤学结局:欧洲泌尿外科学会指南系统评价。
Eur Urol Focus. 2019 Mar;5(2):205-223. doi: 10.1016/j.euf.2017.10.003. Epub 2017 Nov 15.
4
Case Report: Metachronous bilateral upper tract and bladder urothelial carcinoma: a long-term follow-up.病例报告:异时性双侧上尿路及膀胱尿路上皮癌:长期随访
F1000Res. 2023 Jun 26;10:778. doi: 10.12688/f1000research.55516.2. eCollection 2021.
5
[Port-Site Metastasis of an Urothelial Carcinoma after Laparoscopic Nephroureterectomy : A Case Report].[腹腔镜肾输尿管切除术后尿路上皮癌的切口转移:一例报告]
Hinyokika Kiyo. 2017 Oct;63(10):399-402. doi: 10.14989/ActaUrolJap_63_10_399.
6
Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma.保留肾单位的输尿管切除术与根治性肾输尿管切除术治疗上尿路上皮癌的肾功能和肿瘤学结局。
J Urol. 2012 Feb;187(2):429-34. doi: 10.1016/j.juro.2011.09.150. Epub 2011 Dec 15.
7
[Clinical diagnosis and treatment of spontaneous urinary extravasation caused by primary lower ureteral tumor].原发性输尿管下段肿瘤所致自发性尿外渗的临床诊断与治疗
Zhonghua Yi Xue Za Zhi. 2012 Feb 14;92(6):414-6.
8
Efficacy of early ureteral ligation on prevention of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: a prospective single-arm multicenter clinical trial.早期输尿管结扎对预防上尿路尿路上皮癌根治性肾输尿管切除术后膀胱内复发的疗效:一项前瞻性单臂多中心临床试验。
Jpn J Clin Oncol. 2017 Sep 1;47(9):870-875. doi: 10.1093/jjco/hyx085.
9
Smaller decline of renal function after nephroureterectomy predicts poorer prognosis of upper tract urothelial carcinoma: a multicentre retrospective study.肾输尿管切除术后肾功能下降较小预示上尿路上皮癌预后较差:一项多中心回顾性研究。
Jpn J Clin Oncol. 2021 Oct 5;51(10):1577-1586. doi: 10.1093/jjco/hyab081.
10
Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience.内镜与腹腔镜治疗非浸润性上尿路尿路上皮癌:20 年单中心经验。
J Urol. 2013 Jun;189(6):2054-60. doi: 10.1016/j.juro.2012.12.006. Epub 2012 Dec 7.

本文引用的文献

1
Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1.日本食管癌学会编辑的《2022年食管癌诊疗指南》:第1部分。
Esophagus. 2023 Jul;20(3):343-372. doi: 10.1007/s10388-023-00993-2. Epub 2023 Mar 18.
2
Efficacy of Pembrolizumab in Patients With Variant Urothelial Carcinoma: A Multicenter Retrospective Study.帕博利珠单抗治疗变异型尿路上皮癌患者的疗效:一项多中心回顾性研究。
Clin Genitourin Cancer. 2022 Oct;20(5):499.e1-499.e8. doi: 10.1016/j.clgc.2022.05.001. Epub 2022 May 5.
3
Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis.
帕博利珠单抗治疗尿路上皮癌患者的组织学亚型对结局的影响:倾向评分匹配分析。
BJU Int. 2022 Aug;130(2):226-234. doi: 10.1111/bju.15510. Epub 2021 Jul 6.
4
Predictors of Locoregional Recurrence and Delineation of Adjuvant Radiation Therapy Fields for Patients With Upper Tract Urothelial Carcinoma Receiving Nephroureterectomy.接受肾输尿管切除术的上尿路尿路上皮癌患者局部区域复发的预测因素和辅助放疗靶区的划定。
Pract Radiat Oncol. 2021 Sep-Oct;11(5):e468-e476. doi: 10.1016/j.prro.2021.02.005. Epub 2021 Feb 23.
5
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.欧洲泌尿外科学会上尿路尿路上皮癌指南:2020 年更新版。
Eur Urol. 2021 Jan;79(1):62-79. doi: 10.1016/j.eururo.2020.05.042. Epub 2020 Jun 24.
6
Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.膀胱癌临床实践指南(第 3 版). 2020 年 NCCN 版
J Natl Compr Canc Netw. 2020 Mar;18(3):329-354. doi: 10.6004/jnccn.2020.0011.
7
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.帕博利珠单抗作为晚期尿路上皮癌的二线治疗药物。
N Engl J Med. 2017 Mar 16;376(11):1015-1026. doi: 10.1056/NEJMoa1613683. Epub 2017 Feb 17.
8
Squamous cell carcinoma of the renal pelvis.肾盂鳞状细胞癌
J Urol. 2010 May;183(5):2023-4. doi: 10.1016/j.juro.2010.02.2370. Epub 2010 Mar 19.
9
Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract.异环磷酰胺、紫杉醇和顺铂用于晚期非移行细胞尿路上皮癌患者的前瞻性试验。
Urology. 2007 Feb;69(2):255-9. doi: 10.1016/j.urology.2006.10.029.